JAGUAR ANIMAL HEALTH,INC. (NASDAQ:JAGX) Files An 8-K Entry into a Material Definitive AgreementItem 1.01 Entry into a Material Definitive Agreement.
As previously reported, on November22, 2016, Jaguar Animal Health,Inc. (the “Company”) entered into a securities purchase agreement (the “Securities Purchase Agreement”) with certain investors to which the Company agreed, among other things, to issue warrants to purchase up to an aggregate of 1,666,668 shares of Common Stock at an exercise price of $1.00 per share (the “SeriesC Warrants”).
On July31, 2017, the Company entered into Warrant Exercise Agreements (the “Exercise Agreements”) with certain holders of the SeriesC Warrants (the “Exercising Holders”), which Exercising Holders own, in the aggregate, SeriesC Warrants exercisable for 908,334 shares of Common Stock. to the Exercise Agreements, the Exercising Holders and the Company agreed that the Exercising Holders would exercise their SeriesC Warrants with respect to 908,334 shares of Common Stock underlying such SeriesC Warrants for a reduced exercise price equal to $0.40 per share.
The Company expects to receive aggregate gross proceeds of approximately $363,333.60 from the exercise of the SeriesC Warrants by the Exercising Holders.
The description of terms and conditions of the Exercise Agreements set forth herein do not purport to be complete and are qualified in their entirety by reference to the full text of the form of Exercise Agreement, which is attached hereto as Exhibit10.1.
Item 3.03 Material Modifications to Rights of Security Holders.
The information contained above in Item 1.01 is hereby incorporated by reference into this Item 3.03.
Item 9.01 Financial Statements and Exhibits.
(d)Exhibits.
|
Exhibit No. |
Description |
|
10.1 |
Formof Warrant Exercise Agreement |
